open access

Vol 14, No 3 (2017)
Prace kazuistyczne
Get Citation

The use of arypiprazole in pregnant women

Jolanta Klemens, Katarzyna Girczys-Połedniok, Urszula Fronc, Robert Pudlo
Psychiatria 2017;14(3):150-153.

open access

Vol 14, No 3 (2017)
Prace kazuistyczne

Abstract

INTRODUCTION: The article describes a case study of the administration of aripiprazole, a second- generatiotion antypsychotic in a pregnant woman. Due to the relatively short time of application, the knowledge about the potential side effects for the fetus development is limited, which is the main reason for its avoidance in the treatment of pregnant women.

CASE PRESENTATION: The case of 34 years old woman with paranoid schizophrenia treated since 2007 has been described. In the psychopatological picture dominated: delusions of reference, persecutory delusions, social withdrawal, obsessions and compulsions. In 2009 the patient became pregnant. The drugs were discontinued, which resulted in an increase in the severity of delusions. Limited concentration, obsessions and psychotic anxiety prevented from professional activity. After the delivery, administration of aripiprazole resulted in improvement of the mental status. Persistent delusions did not have the impact on behaviour procedeed with partial judgment. In 2014 the patient got pregnat for the second time. Because of the previous severe course of the disease, the treatment was maintained. Te patient’s mental status was balanced, psychotic disorders did not occur, negative symptoms of schizophrenia were not observed. After the natural childbirth, lactation delay and productive symptoms were observed. The latter symptom caused the need to increase the dose of the aripiprazole.

CONCLUSIONS: Aripiprazole turned out to be a good choice for a pregnant woman, she was free of psychotic sensations and accompanying anxiety. It beneficially affected the mental state during the pregnancy, childbirth and puerperium. Three weeks after the delivery, it was necessary to increase the dosage of the drug, as the psychotic induced anxiety occured. These disorders subsided after increasing the dosage of the drug.

Abstract

INTRODUCTION: The article describes a case study of the administration of aripiprazole, a second- generatiotion antypsychotic in a pregnant woman. Due to the relatively short time of application, the knowledge about the potential side effects for the fetus development is limited, which is the main reason for its avoidance in the treatment of pregnant women.

CASE PRESENTATION: The case of 34 years old woman with paranoid schizophrenia treated since 2007 has been described. In the psychopatological picture dominated: delusions of reference, persecutory delusions, social withdrawal, obsessions and compulsions. In 2009 the patient became pregnant. The drugs were discontinued, which resulted in an increase in the severity of delusions. Limited concentration, obsessions and psychotic anxiety prevented from professional activity. After the delivery, administration of aripiprazole resulted in improvement of the mental status. Persistent delusions did not have the impact on behaviour procedeed with partial judgment. In 2014 the patient got pregnat for the second time. Because of the previous severe course of the disease, the treatment was maintained. Te patient’s mental status was balanced, psychotic disorders did not occur, negative symptoms of schizophrenia were not observed. After the natural childbirth, lactation delay and productive symptoms were observed. The latter symptom caused the need to increase the dose of the aripiprazole.

CONCLUSIONS: Aripiprazole turned out to be a good choice for a pregnant woman, she was free of psychotic sensations and accompanying anxiety. It beneficially affected the mental state during the pregnancy, childbirth and puerperium. Three weeks after the delivery, it was necessary to increase the dosage of the drug, as the psychotic induced anxiety occured. These disorders subsided after increasing the dosage of the drug.

Get Citation

Keywords

psychotic disorders, aripiprazole, pregnancy, atypical antipsychotics

About this article
Title

The use of arypiprazole in pregnant women

Journal

Psychiatria (Psychiatry)

Issue

Vol 14, No 3 (2017)

Pages

150-153

Bibliographic record

Psychiatria 2017;14(3):150-153.

Keywords

psychotic disorders
aripiprazole
pregnancy
atypical antipsychotics

Authors

Jolanta Klemens
Katarzyna Girczys-Połedniok
Urszula Fronc
Robert Pudlo

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Psychiatria dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest Via Medica sp. z o.o. sp. komandytowa, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl